JUNE MEDICAL LTD

Company Registration Number:
08612384 (England and Wales)

Unaudited abridged accounts for the year ended 31 March 2025

Period of accounts

Start date: 01 April 2024

End date: 31 March 2025

JUNE MEDICAL LTD

Contents of the Financial Statements

for the Period Ended 31 March 2025

Balance sheet
Notes

JUNE MEDICAL LTD

Balance sheet

As at 31 March 2025


Notes
2025
2024


£
£
Fixed assets
Intangible assets: 3 0 872
Tangible assets: 4 321,607 323,692
Total fixed assets: 321,607 324,564
Current assets
Stocks: 110,394 103,642
Debtors:   168,630 196,511
Cash at bank and in hand: 254,179 136,089
Total current assets: 533,203 436,242
Creditors: amounts falling due within one year:   (181,459) (111,880)
Net current assets (liabilities): 351,744 324,362
Total assets less current liabilities: 673,351 648,926
Creditors: amounts falling due after more than one year:   (255,255) (314,405)
Total net assets (liabilities): 418,096 334,521
Capital and reserves
Called up share capital: 2 2
Profit and loss account: 418,094 334,519
Shareholders funds: 418,096 334,521

The notes form part of these financial statements

JUNE MEDICAL LTD

Balance sheet statements

For the year ending 31 March 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 08 October 2025
and signed on behalf of the board by:

Name: A Spang
Status: Director

The notes form part of these financial statements

JUNE MEDICAL LTD

Notes to the Financial Statements

for the Period Ended 31 March 2025

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

JUNE MEDICAL LTD

Notes to the Financial Statements

for the Period Ended 31 March 2025

2. Employees

2025 2024
Average number of employees during the period 7 7

JUNE MEDICAL LTD

Notes to the Financial Statements

for the Period Ended 31 March 2025

3. Intangible Assets

Total
Cost £
At 01 April 2024 4,632
At 31 March 2025 4,632
Amortisation
At 01 April 2024 3,760
Charge for year 872
At 31 March 2025 4,632
Net book value
At 31 March 2025 0
At 31 March 2024 872

JUNE MEDICAL LTD

Notes to the Financial Statements

for the Period Ended 31 March 2025

4. Tangible Assets

Total
Cost £
At 01 April 2024 350,939
Additions 500
At 31 March 2025 351,439
Depreciation
At 01 April 2024 27,247
Charge for year 2,585
At 31 March 2025 29,832
Net book value
At 31 March 2025 321,607
At 31 March 2024 323,692